These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19822773)

  • 1. Immunotherapy for multiple sclerosis: the curious case of interferon beta.
    Stüve O; Ransohoff RM
    Arch Neurol; 2009 Oct; 66(10):1193-4. PubMed ID: 19822773
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple sclerosis therapeutics: unexpected outcomes clouding undisputed successes.
    Wiendl H; Hohlfeld R
    Neurology; 2009 Mar; 72(11):1008-15. PubMed ID: 19289741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-based therapy of multiple sclerosis.
    Kaufman MD
    N C Med J; 1995 Aug; 56(8):379-84. PubMed ID: 7566191
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhancement of chemokine expression by interferon beta therapy in patients with multiple sclerosis.
    Cepok S; Schreiber H; Hoffmann S; Zhou D; Neuhaus O; von Geldern G; Hochgesand S; Nessler S; Rothhammer V; Lang M; Hartung HP; Hemmer B
    Arch Neurol; 2009 Oct; 66(10):1216-23. PubMed ID: 19667211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopathogenesis and immunotherapeutic approaches in multiple sclerosis.
    Lim ET; Giovannoni G
    Expert Rev Neurother; 2005 May; 5(3):379-90. PubMed ID: 15938671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multiple sclerosis--immunopathogenesis, traditional therapeutic strategy and suggested combined immunotherapy].
    Skotnicki AB; Aleksandrowicz J; Retinger-Grzesiuła M; Zduńczyk A; Grochmal S; Huczyński J
    Postepy Hig Med Dosw; 1983; 37(1):1-32. PubMed ID: 6356094
    [No Abstract]   [Full Text] [Related]  

  • 7. [Causal therapy of multiple sclerosis].
    Pöhlau D; Rieks M; Postert T; Hoffmann V; Przuntek H
    Dtsch Med Wochenschr; 1996 Nov; 121(45):1407-14. PubMed ID: 8964231
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunological basis for the therapy of multiple sclerosis.
    Hohlfeld R
    Acta Neurol Belg; 1999 Mar; 99(1):40-3. PubMed ID: 10218091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic strategies in multiple sclerosis. I. Immunotherapy.
    Hohlfeld R
    Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1697-710. PubMed ID: 10603621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of multiple sclerosis].
    Bereznai B; Goebels N; Dang T; Voltz R; Walther E; Zimmermann C; Hohlfeld R
    Dtsch Med Wochenschr; 1999 May; 124(19):595-9. PubMed ID: 10365178
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pragmatic approach to treatments in multiple sclerosis].
    Vermersch P
    Rev Neurol (Paris); 2009 Apr; 165 Spec No 2():F125-31. PubMed ID: 19593885
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic and symptomatic treatment of multiple sclerosis.
    Rosenblum D; Saffir M
    Phys Med Rehabil Clin N Am; 1998 Aug; 9(3):587-601, vi-vii. PubMed ID: 9894111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Abnormalities in the immune system of MS patients and possibilities of immunological treatment].
    Salonen R; Ilonen J
    Duodecim; 1992; 108(1):82-92. PubMed ID: 1365988
    [No Abstract]   [Full Text] [Related]  

  • 14. Multiple sclerosis. Treatment is shifting.
    Mayo Clin Health Lett; 2003 Jan; 21(1):6. PubMed ID: 12619619
    [No Abstract]   [Full Text] [Related]  

  • 15. Rational clinical immunotherapy for multiple sclerosis.
    Hunter SF; Weinshenker BG; Carter JL; Noseworthy JH
    Mayo Clin Proc; 1997 Aug; 72(8):765-80. PubMed ID: 9276606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognosis improves through early therapy from the beginning!].
    Med Monatsschr Pharm; 2007 Oct; 30(10):381-2. PubMed ID: 17966289
    [No Abstract]   [Full Text] [Related]  

  • 17. [Nervous system diseases with immunologic disorders--present status of immunotherapy].
    Ono R; Hamaguchi K
    Nihon Naika Gakkai Zasshi; 1993 Jan; 82(1):122-6. PubMed ID: 7681462
    [No Abstract]   [Full Text] [Related]  

  • 18. [Oral therapy for multiple sclerosis!].
    de Seze J
    Rev Neurol (Paris); 2010 Apr; 166(4):363-4. PubMed ID: 20385331
    [No Abstract]   [Full Text] [Related]  

  • 19. Behind the paper: saved from the drain.
    Dolgin E
    Nat Med; 2010 Apr; 16(4):378. PubMed ID: 20376044
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunosuppressive therapy of multiple sclerosis].
    Mavra M; Lević Z; Nikolić M
    Srp Arh Celok Lek; 1979; 107(7-8):663-71. PubMed ID: 531687
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.